US health panel recommends easing restrictions on controversial peptides
Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals have not been shown to be safe or effective.
In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names like BPC-157, TB-500 and KPV.
Continue reading...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
같은 사건, 다른 제목
US health panel recommends easing restrictions on controversial peptides
FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
FDA considers green-lighting unproven peptide injections boosted by RFK Jr as scientists issue warnings
FDA panel to consider loosening regulations for some peptides
+3
FDA considers widening access to peptides promoted by wellness influencers
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
FDA panel confronting peptide controversy
WATCH LIVE: FDA advisory panel considers use of peptides
+4